Twist Bioscience
TWST
#4691
Rank
HK$15.37 B
Marketcap
HK$251.44
Share price
-1.55%
Change (1 day)
-36.32%
Change (1 year)
Categories

Revenue for Twist Bioscience (TWST)

Revenue in 2025 (TTM): HK$2.82 Billion

According to Twist Bioscience 's latest financial reports the company's current revenue (TTM ) is HK$2.82 Billion. In 2024 the company made a revenue of HK$2.56 Billion an increase over the revenue in the year 2023 that were of HK$2.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Twist Bioscience from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$2.82 B10.13%
2024 HK$2.56 B25.1%
2023 HK$2.04 B21.53%
2022 HK$1.68 B47.9%
2021 HK$1.13 B45.45%
2020 HK$0.78 B67.56%
2019 HK$0.46 B83.19%
2018 HK$0.25 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 B 77.29% Jersey
Novavax
NVAX
HK$7.97 B 182.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.17 B-93.97%๐Ÿ‡ฌ๐Ÿ‡ง UK